Evidence map›Paper›PMID 26141329›Full record

ArticleMayo Clinic proceedings2015

Incidence of Infective Endocarditis Due to Viridans Group Streptococci Before and After the 2007 American Heart Association's Prevention Guidelines: An Extended Evaluation of the Olmsted County, Minnesota, Population and Nationwide Inpatient Sample.

Daniel C DeSimone, Imad M Tleyjeh, Daniel D Correa de Sa, Nandan S Anavekar, Brian D Lahr, Muhammad R Sohail, James M Steckelberg, Walter R Wilson, Larry M Baddour, Mayo Cardiovascular Infections Study Group

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Mayo Clinic proceedings, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Epidemiology of infective endocarditis beforeTherapeutic advances in cardiovascular disease
    Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Infective endocarditis in the 21st century.Annals of translational medicine · 2020
    Article
  14. Review
  15. The epidemiological and clinical features of odontogenic infective endocarditis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Daniel C DeSimoneDivision of Infectious Diseases, Mayo Clinic, Rochester, MN. Electronic address: desimone.daniel@mayo.edu.
Imad M TleyjehDivision of Infectious Diseases, Mayo Clinic, Rochester, MN; Division of Infectious Diseases, King Fahd Medical Center, Riyadh, Saudi Arabia.
Daniel D Correa de SaPrairie Cardiovascular Consultants, Carbondale, IL.
Nandan S AnavekarDivision of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
Brian D LahrDivision of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN.
Muhammad R SohailDivision of Infectious Diseases, Mayo Clinic, Rochester, MN; Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
James M SteckelbergDivision of Infectious Diseases, Mayo Clinic, Rochester, MN.
Walter R WilsonDivision of Infectious Diseases, Mayo Clinic, Rochester, MN.
Larry M BaddourDivision of Infectious Diseases, Mayo Clinic, Rochester, MN.
Mayo Cardiovascular Infections Study Group
Mayo Clinic in Arizona · USMayo Clinic · USPrairie Vascular Institute · US

Funding

Rochester Epidemiology ProjectR01AG034676 · NIA · MAYO CLINIC ROCHESTER · PI ROCCA, WALTER A, ST SAUVER, JENNIFER LYNN · 2010 to 2019
$9.5M
NIA NIH HHS R01 AG034676NIA NIH HHS R01-AG034676
6 · The paper itself

Abstract

objectiveTo determine whether the incidence of infective endocarditis (IE) due to viridans group streptococci (VGS) increased after the publication of the 2007 American Heart Association (AHA) IE prevention guidelines. PATIENTS AND

methodsWe performed a population-based survey of all adults (18 years and older) residing in Olmsted County, Minnesota, from January 1, 1999, through December 31, 2013, to identify definite or possible cases of VGS-IE using the Rochester Epidemiology Project. The National (Nationwide) Inpatient Sample hospital discharge database was examined to determine the number of VGS-IE cases in the United States between 2000 and 2011.

resultsRates of incidence (per 100,000 person-years) during the intervals of 1999-2002, 2003-2006, 2007-2010, and 2011-2013 were 3.6 (95% CI, 1.3-5.9), 2.7 (95% CI, 0.9-4.4), 0.7 (95% CI, 0.0-1.6), and 1.5 (95% CI, 0.2-2.9), respectively, reflecting an overall significant decrease (P=.03 from Poisson regression). Likewise, nationwide estimates of hospital discharges with a VGS-IE diagnosis trended downward during 2000-2011, with a mean number per year of 15,853 and 16,157 for 2000-2003 and 2004-2007, respectively, decreasing to 14,231 in 2008-2011 (P=.05 from linear regression using weighted least squares method).

conclusionDespite major reductions in the number of indications for antibiotic prophylaxis for invasive dental procedures espoused by the 2007 AHA IE prevention guidelines, both local and national data indicate that the incidence of VGS-IE has not increased.

Indexed as

Guideline AdherenceRisk AssessmentAdolescentAdultAgedAged, 80 and overAmerican Heart AssociationAntibiotic ProphylaxisEndocarditisFemaleHumansIncidenceInpatientsMaleMiddle AgedPopulation Surveillance

Identifiers

PMID26141329
PMCPMC4560595
OpenAlexW1493327700

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.